Alkeus Pharmaceuticals
Clinical-stage biotechnology company developing gildeuretinol (ALK-001) for the treatment of Stargardt disease and other inherited retinal degenerations.
Website
https://www.alkeuspharma.comLocation
Boston, Massachusetts, USA
Founded
2010
Categories
biotech, rare-disease, ophthalmology, therapeutics
